The structure of the monomeric form of perfringolysin O solved by X-ray crystallography has been used to model the very large transmembrane pore formed when this bacterial protein toxin assembles in cholesterolcontaining membranes. The structure is a notable advance, but it may not provide the whole story. Address Proteins that form sizeable holes in membranes (as opposed to narrow channels) are ubiquitous in nature and include bacterial toxins, bacterial and mitochondrial porins, proteins involved in host-cell penetration and lysis by bacteriophage, the translocons required for protein secretion and membrane protein assembly, gap junctions, nuclear pores, poreforming proteins of the immune system, and more. Three-dimensional structures at atomic resolution have been obtained by X-ray crystallography for several poreforming toxins that allow the passage of small molecules of around 1000 Da (reviewed in [1]). With the notable exception of porins, this is all the structural information we have about pore-forming proteins. Conspicuously lacking has been the structure of a protein capable of forming very large pores that can, for example, allow the passage of folded proteins. Hence, the recently solved structure of a monomeric form of perfringolysin O (PFO, theta toxin) from Clostridium perfringens is a major step forward [2] .
Proteins that form sizeable holes in membranes (as opposed to narrow channels) are ubiquitous in nature and include bacterial toxins, bacterial and mitochondrial porins, proteins involved in host-cell penetration and lysis by bacteriophage, the translocons required for protein secretion and membrane protein assembly, gap junctions, nuclear pores, poreforming proteins of the immune system, and more. Three-dimensional structures at atomic resolution have been obtained by X-ray crystallography for several poreforming toxins that allow the passage of small molecules of around 1000 Da (reviewed in [1] ). With the notable exception of porins, this is all the structural information we have about pore-forming proteins. Conspicuously lacking has been the structure of a protein capable of forming very large pores that can, for example, allow the passage of folded proteins. Hence, the recently solved structure of a monomeric form of perfringolysin O (PFO, theta toxin) from Clostridium perfringens is a major step forward [2] .
A family of cytolysins
PFO is a member of the expanding family of cytolysins epitomized by streptolysin O (SLO) [3, 4] . In most cases, these proteins are secreted as monomers of 50-80 kDa. Amino-terminal extensions of various lengths account for differences in mass and the remaining 450 carboxy-terminal residues are 40-70% identical. The biological activity of the SLO family depends on the presence of membrane cholesterol, and is inhibited by nanomolar concentrations of free cholesterol and closely related sterols [3] .
Proteins of the SLO family oligomerize to form transmembrane pores more than 30 nm in external diameter, containing 40-80 monomers per pore, which appear as spectacular, large, circularized structures by electron microscopy ( Figure 1 ) [5] . Individual members of the family contain rings with a variable number of subunits (for example, 40-50 for pneumolysin (PLY) [4] ). In this regard, these structures, with large radii of curvature, fall between small pores, which have fixed numbers of subunits, and linear protein polymers of variable length. The pores contain no additional polypeptides and have no receptor other than cholesterol. The circular structures are often incomplete and 'banana-like' structures or arcs are seen by electron microscopy [5] . Like circular pores, these arcs also cause the target cells to leak, as suggested by osmotic protection experiments (M. Palmer and S. Bhakdi, personal communication) and planar bilayer recordings [6] .
SLO and its relatives are virulence factors. Their mode of action is now viewed as being more subtle than the 'Rambo-style' blowing of holes in cell membranes. Sublytic concentrations of the toxins are involved in numerous physiological changes associated with infection, including the release of potent protein factors, such as tumor necrosis factor α and interleukin-1β [4, 7] . These events are presumably initiated by the stimulation of intracellular signal transduction pathways by Ca 2+ influx, for example. In addition, the activation of phospholipases, by an unknown Figure 1 Electron micrographs of streptolysin O [5] . Purified SLO complexes were incorporated into cholesterol-free liposomes and negatively stained with sodium silicotungstate. Complete rings (a) and an arc (b) are displayed. SLO projects about 5 nm from the outer surface of the bilayer, as seen in (c) as profile views (labelled with p). As the total height of the structure is about 9.5 nm, there is probably little protein projecting from the inner surface of the bilayer. The scale bar corresponds to 100 nm. mechanism, can catalyze the release of lipid-derived signaling molecules [4, 7] . Proteins of the SLO family are also able to activate the classical complement pathway in the absence [4] or the presence of anti-toxin antibodies [8] . Complement fixation may serve to divert host defences from the bacterium or to induce attack by complement on host cell membranes [4, 8] .
Structure of perfringolysin O
The structure of monomeric PFO has been determined to 2.7 Å resolution by X-ray diffraction by Jamie Rossjohn and colleagues in Michael Parker's laboratory [2] . The molecule is elongated (11.5 × 3 × 5.5 nm) and comprises four domains that are rich in β-sheet structure (Figure 2 ). Perhaps the only direct clue from the structure about pore formation is the location of a tryptophan-rich sequence at one end of the rod in the carboxy-terminal domain 4 ( Figure 2 ). This sequence, ECTGLAWEWWR (singleletter amino-acid code), is highly conserved in the SLO family. Mutagenesis suggests that the integrity of the sequence is important for activity: in many point mutants, the binding and oligomerization properties are retained, but activity is lost (Figure 2) . By contrast, in other mutants and after chemical modification of the cysteine residue, the protein no longer binds to membranes. Additional mutations that weaken the affinity of SLO family members for membranes lie elsewhere in domain 4 near the carboxyl terminus ( Figure 2) . Much of the mutagenesis data [3, 4, 9] is unsatisfying, however, because binding to free cholesterol and binding to membranes should be distinguished, studies of oligomerization are not or cannot be performed quantitatively and cell lysis is not a simple linear process like a typical enzyme assay. Nevertheless, because all the mutations that affect binding fall in the structurally autonomous domain 4, the data on balance suggest that cholesterol binds somewhere in this domain. In support of this view, proteolytic fragments of PFO and PLY that contain predominantly domain 4 bind to cholesterol and to cholesterol-containing membranes. These fragments form arcs but are nonlytic and prevent lysis by intact PFO, presumably by blocking intersubunit interactions [10] .
Despite the complexities of the binding data, Rossjohn and colleagues [2] envision a binding site for cholesterol in the tryptophan-rich region of domain 4, remodeling the polypeptide before docking the steroid. They suggest that the tryptophan-rich motif and the cholesterol molecule combine to form a 'dagger' capable of membrane penetration. In support of this proposal, the fluorescence of tryptophans in domain 4 of PFO is quenched after assembly on liposomes containing brominated lipids [10] . Moreover, aromatic residues in transmembrane proteins often cluster near the interface of the membrane and the aqueous phase [1, 11] .
Another striking feature of domain 4 is the fold, which resembles transthyretin, a protein that forms amyloid-like polymers with intermolecular β sheets [12] that may be required for the assembly of PFO (see below), as well as other toxin pores [1, 13] . A region of the protein that has been implicated in complement activation is also in domain 4 [4] , but distant from the tryptophan-rich motif ( Figure 2 ). Domain 1, as well as domain 4, has previously been implicated in oligomerization. Notably, a monoclonal antibody that binds here, close to the interface with domain 3 (Figure 2 ), allows membrane binding but prevents oligomerization [14] .
A model for membrane insertion
Based on their structure of the monomer and electron micrographs from previous studies, Rossjohn and colleagues [2] have devised a model for membrane insertion by PFO (Figure 3a) , which is likely to be both influential and controversial. In Rossjohn's scheme [2] , individual subunits descend onto a lipid bilayer where they find cholesterol-rich patches and then oligomerize. Cholesterol bound in the oligomers causes a rearrangement of the tryptophan-rich motif to form the hydrophobic dagger that penetrates the bilayer. Important features of the model for membrane insertion include: oligomerization prior to membrane penetration; strong interactions between domains 1 well above the membrane surface; bending at the interface between domains 1 and 3 to form a continuous intramolecular β sheet; domain 4 as the exclusive membrane-penetrating domain; reorganization of domain 4 to bind cholesterol; the presence of bound cholesterol in the arcs and rings to protect a hydrophilic face of domain 4 within the bilayer; and the formation of a continuous intermolecular β sheet around the entire structure by one face of domain 4.
How good is the model?
There are arguments in favor of many aspects of the model; for example, there are relatively modest changes in secondary structure during assembly [10] . Other features will be seen as questionable or unresolved, however, and thereby present a valuable stimulus for further experimentation. For instance, the shape of the proposed membrane-inserted structure agrees fairly well with images obtained by electron microscopy (references in [2] ), but does not withstand close scrutiny. From electron microscopy, the total height of the structure is 9-10 nm, with about 5 nm projecting above the bilayer surface. The longest dimension in the crystal is 11.5 nm, which should correspond to the height of the uninserted subunits. According to the model, each subunit becomes elongated upon insertion to about 14 nm, 8.5 nm of which projects above the membrane surface, and this clearly conflicts with the electron microscopy data. The periodicity at the outer limit of the ring (2.4 nm) is, however, a reasonable fit with the crystal structure (3 nm dimension). The width of the ring is 4.8-7.5 nm, which corresponds roughly to the 5.5 nm dimension in the crystal. The variation in observed width between different studies by electron microscopy does not seem to correlate with the variable mass of the amino-terminal domain in the SLO family.
Kinetic studies tell us that monomeric SLO binds reversibly to membranes, dimer formation is rate limiting, and elongation to arcs is relatively rapid, providing the basis of an alternative model for assembly (Figure 3b ) [15] . Membrane leakage can be induced by small oligomers ( [6] ; M. Palmer and S. Bhakdi, personal communication), which suggests that membrane penetration is an early event. By contrast, the scheme of Rossjohn and colleagues indicates that extensive oligomerization occurs before membrane penetration. Arcs cause larger leaks in the membrane, which implies that the bilayer is grossly disrupted in the vicinity of these structures. The Rossjohn paper [2] makes no suggestions about how the boundary of the lipid appears in the arcs and how the rearranged bilayer would form an interface with the protein [5] .
The Rossjohn model also suggests that cholesterol is intimately associated with membrane-inserted PFO arcs and rings. However, extensively delipidated SLO rings can be reconstituted in cholesterol-free bilayers and appear perfectly accommodated [5] , although it is not certain that one remaining equivalent of tightly bound cholesterol would have been detected in these studies. PLY oligomers can form from highly concentrated solutions of Dispatch R765
Figure 3
Two models for the formation of arcs and rings by the SLO family of toxins. (a) A model based closely on that of Rossjohn and colleagues [2] . PFO binds to the membrane at a cholesterol-rich patch through domain 4 (cholesterol molecules are shown in green). Oligomers then form on the membrane surface. Finally, the oligomers insert into the membrane to form an arc or ring in which a cholesterol molecule is retained by domain 4 and protects a hydrophilic face of the protein from the hydrocarbon core of the bilayer. The ring projects about 8.5 nm from the bilayer surface. (b) Model for assembly based on the additional biochemical and biophysical studies discussed in the text. The monomer binds to the bilayer in a reversible step that requires cholesterol and most probably involves domain 4 directly. In a rate-determining step, the monomers dimerize and segments of the polypeptide including sequences in domain 3 insert into the bilayer. A role for cholesterol beyond this step has not been proven and, therefore, the cholesterol may be released as shown. The dimer elongates by the addition of additional membrane-bound monomers that insert into the membrane as they enter the complex. The membrane is breached by the growing arcs. Finally, a large arc or ring is formed that projects about 5 nm from the membrane and does not require annular cholesterol for structural stability. This slow nucleation followed by rapid propagation is similar to the way in which amyloid proteins polymerize, except that, in the case of the toxins, termination occurs upon circularization.
monomer in the absence of cholesterol, and these sterolfree assemblies do not bind cholesterol (R. Gilbert, personal communication). Specifically, Rossjohn and colleagues suggest that one of the faces of domain 4 that enters the bilayer is polar and must, therefore, be shielded by cholesterol, which seems unlikely given the physical properties of this molecule -a C 27 hydrocarbon with just a single hydroxyl group, normally located in the headgroup region of the bilayer. Evidence for masking of a hydrophilic site for membrane insertion has been obtained for an activation domain of protein kinase Cδ, where phorbol ester covers a polar groove on a predominantly hydrophobic surface of the protein [16] .
In further conflict with details of the model, scanning mutagenesis and fluorescence emission experiments suggest that at least part of domain 3 enters the lipid bilayer [17] . In this approach, a dye such as acrylodan, which shows a large blue shift in emission upon transfer from a hydrophilic environment into a hydrophobic one, is attached at single cysteines in a polypeptide: fluorescence emission spectra are recorded before and after assembly [18, 19] . In the case of SLO, a relatively small number of fluorescent mutants -19 -have been published so far. The studies suggest that residues 274 (204), 286 (216) and 403 (333) in domain 3 (PFO residue numbers in parentheses) are in contact with the lipid bilayer (Figure 2 ).
Resolving the matter
The Rossjohn model is a thought-provoking scheme quite different from the assembly pathways proposed or substantiated for other pore-forming proteins. These pathways are largely based on the formation of transmembrane helix bundles or β barrels with internally hydrogenbonded backbones and non-polar side chains in contact with the hydrocarbon core of the bilayer. In this regard, however, it is important to remember that α-hemolysin is the only pore-forming toxin for which the structure of the transmembrane region has actually been solved [1] . It would therefore be wonderful to see the three-dimensional structure of a PFO ring or an arc, but this is an unlikely prospect, firstly because of the heterogeneity of rings and arcs, and secondly because of the difficulty in crystallizing large, water-filled objects, which would present a minimum of protein contacts and a deformable structure. The structure of a dimer formed by a wild-type monomer and a mutant that caps the nucleated arc is a more realistic endeavor. Nuclear magnetic resonance is also problematic for such large molecules. Infra-red spectroscopy, circular dichroism, intrinsic fluorescence and related techniques, in which the signal cannot be assigned to specific residues without considerable effort, have also been of little use in such situations, even where oriented samples have been examined. Therefore, some ingenuity will be required to construct viable structures by using cryo-electron microscopy, scanning force microscopy and model building, supported by additional biochemical data. Approaches that yield information for the SLO family will be applicable to other large pores, which include the membrane-attack complex of complement, perforin, holins (the phage lysis proteins) and nuclear pores.
Targeted chemical modification with spectroscopic probes will continue to be useful for identifying the disposition of residues in membrane proteins, such as residues that contact the hydrocarbon core of the bilayer or line the lumen of the transmembrane channel, or residues that are involved in subunit contacts and conformational changes. Electron paramagnetic resonance experiments in which probes are attached to single cysteines [20] are a useful alternative to the fluorescence approach. Difficulties may arise with these approaches if membrane lipids, such as cholesterol, bind tightly to sites on the toxin: for example, the covalently attached probe might disrupt an important interaction with the sterol. Furthermore, it may not always be possible to assign secondary structure to membraneinserted sequences because the probe may perturb locally flexible domains [18, 19] . To identify residues that line the lumen of the transmembrane channel in the arcs and pores, variations of surface cysteine-labeling techniques should prove useful [21] . These techniques are especially powerful when combined with functional measurements, especially single-channel recording. However, new bulky or highly charged probes will be needed to alter significantly the conductances of the large pores of the SLO family.
In the scanning mutagenesis and fluorescence approach, it is perilous to omit even short stretches of residues (8-10 residues of a β sheet can span a bilayer) and schemes in which entire proteins or at least entire domains are subjected to single cysteine substitution at every position are recommended. Furthermore, quenching nitroxyl or halogenated lipids should be used to confirm movement into the bilayer, and water-soluble quenchers of various sizes should be used to identify positions in the lumen of a transmembrane channel [22] . The effort expended in a comprehensive cysteine scan can be useful in other ways: for example, intramolecular and intermolecular disulfides can be used to clamp the polypeptide and might be useful for testing the strong domain 1-domain 1 interaction proposed for PFO [2] .
There is also a pressing need for better identification of the residues involved in binding cholesterol. First, it should be recognized that the cholesterol dependence of SLO and its relatives differs fundamentally from that of eukaryotic membrane proteins such as rhodopsin, Ca 2+ -ATPase and the nicotinic acetylcholine receptor. The latter have an ill-defined number of relatively weak, fairly non-specific cholesterol-binding sites, whereas the toxins bind a few sterol molecules, perhaps one, rather specifically with an affinity of ~10 -9 M [3] . Domain 4 is by far the best candidate for the site, but there is no evidence that the region around the conserved cysteine is directly involved. Photoaffinity labeling is a possible approach to examine a chemically unreactive binding site. Alternatively, single cysteine mutants might be screened for reactivity with alkylating derivatives of cholesterol. In addition, the role of cholesterol at each stage in assembly needs to be fully defined. Some would claim that cholesterol partakes solely in the binding step (Figure 3b ), whereas the Rossjohn paper sees a role for cholesterol throughout assembly and in stabilizing the assembled arcs and pores (Figure 3a) . Here, the use of lipid derivatives that keep cholesterol on one side of the bilayer or fix its orientation in the membrane might be helpful [23] . Brominated sterols might also be used as quenchers in conjunction with fluorescence experiments.
While studies of structure continue, it should not be forgotten that we need to know more about the steps in assembly and their kinetics. Even the crudest outline of an assembly pathway ( Figure 3 
